Optimizing Foundational Therapies in Patients With HFrEF: How Do We Translate These Findings Into Clinical Care?
作者:
关键词
ACE, angiotensin-converting enzymeARB, angiotensin receptor blockerARNI, angiotensin receptor neprilysin inhibitorBB, beta-blockerGDMT, guideline-directed medical therapyHF, heart failureHFrEF, heart failure with reduced ejection fractionMRA, mineralocorticoid receptor agonistSGLT2i, sodium–glucose co-transporter 2 inhibitorT2DM, type 2 diabetes mellitusangiotensin receptor–neprilysin inhibitorbeta-blockerseGFR, estimated glomerular filtration ratemineralocorticoid receptor antagonistssodium–glucose co-transporter 2 inhibitors
DOI
10.1016/j.jacbts.2021.10.018
PMID
35663626
发布时间
2022-07-16
- 浏览1

JACC. Basic to translational science
2022年7卷5期
504-517页
相似文献
- 中文期刊
- 外文期刊
- 学位论文
- 会议论文